Health
Horizon Discovery licenses CHOSOURCE to Sanyou Biopharmaceuticals Co. – News-Medical.net
Horizon Discovery today announced that it has granted commercial licenses for its cGMP-compliant CHOSOURCE™ platform to Sanyou Biopharmaceuticals.
Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that it has granted two commercial licenses for its cGMP-compliant CHOSOURCE™ platform to Sanyou Biopharmaceuticals Co., Ltd., a leading biotechnology company focused on research, development and providing integrated solutions for innovative antibody drug developments.
Sanyou will use Horizon’s gene-edited Glutamine Synthetase (GS) knockout Chinese Hamster…
-
General24 mins agoFerries and celebrities as pollies dash to win the west
-
Noosa News20 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
General21 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Noosa News23 hours agoVHM’s Goschen Rare Earths and Mineral Sands Project granted 20-year licence